Search
for
Sort by
Research 211–240 of 755
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Androgenetic alopecia, hirsutism and hypertrichosis
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Polycystic Ovary Syndrome
- Endocrinology of Transgender Medicine
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Testosterone therapy for transgender men
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Polycystic Ovary Syndrome
- Diagnosis of hyperandrogenism: clinical criteria
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- How to diagnose a lipodystrophy syndrome
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Idiopathic Hirsutism*
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome